{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:54:21Z","timestamp":1791500061969,"version":"4.3.4"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cca.2024.119857","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T13:40:33Z","timestamp":1720446033000},"page":"119857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Biomarkers in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"562","author":[{"given":"Kayalvizhi","family":"Rajendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Maheswari","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.119857_b0005","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.cca.2024.119857_b0010","article-title":"Global and regional spending on dementia care from 2000\u20132019 and expected future health spending scenarios from 2020\u20132050: An Economic Modelling Exercise","volume":"45","author":"Pedroza","year":"2022","journal-title":"eClinical Medicine"},{"key":"10.1016\/j.cca.2024.119857_b0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1590\/S1980-57642009DN30300003","article-title":"Neurobiological pathways to Alzheimer\u2019s disease: Amyloid-beta, TAU protein or both?","volume":"3","author":"Paula","year":"2009","journal-title":"Dement. Neuropsychol."},{"key":"10.1016\/j.cca.2024.119857_b0020","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer\u2019s Disease: Treatment Strategies and Their Limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0025","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and Future Treatments in Alzheimer Disease: An Update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.cca.2024.119857_b0030","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1038\/s41598-020-74399-w","article-title":"Multimodal deep learning models for early detection of Alzheimer\u2019s disease stage","volume":"11","author":"Venugopalan","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.119857_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1031833","article-title":"Biosensors toward behavior detection in diagnosis of alzheimer\u2019s disease","volume":"10","author":"Sun","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.cca.2024.119857_b0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fneur.2015.00142","article-title":"Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD","volume":"6","author":"Schindler","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer\u2019s disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.cca.2024.119857_b0050","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1038\/s41598-021-89004-x","article-title":"Highly specific and ultrasensitive plasma test detects Abeta(1\u201342) and Abeta(1\u201340) in Alzheimer\u2019s disease","volume":"11","author":"Thijssen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.119857_b0055","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41596-021-00511-7","article-title":"Microfluidic integration of regeneratable electrochemical affinity-based biosensors for continual monitoring of organ-on-a-chip devices","volume":"16","author":"Aleman","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cca.2024.119857_b0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0065","doi-asserted-by":"crossref","first-page":"e12921","DOI":"10.15252\/emmm.202012921","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected","volume":"12","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cca.2024.119857_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2019.100005","article-title":"Diagnostic biomarkers of Alzheimer\u2019s disease: A state-of-the-art review","volume":"1","author":"Khoury","year":"2019","journal-title":"Biomark. Neuropsychiatry"},{"key":"10.1016\/j.cca.2024.119857_b0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40120-019-00168-1","article-title":"Salivary Biomarkers for Alzheimer\u2019s Disease and Related Disorders","volume":"8","author":"Ashton","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-022-01003-w","article-title":"The cerebrospinal fluid biomarker ratio A\u03b242\/40 identifies amyloid positron emission tomography positivity better than A\u03b242 alone in a heterogeneous memory clinic cohort","volume":"14","author":"Amft","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/acn3.274","article-title":"CSF A\u03b242\/A\u03b240 and A\u03b242\/A\u03b238 ratios: better diagnostic markers of Alzheimer disease","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0095","doi-asserted-by":"crossref","unstructured":"P. Lewczuk, A. Matzen, K. Blennow, L. Parnetti, J.L. Molinuevo, P. Eusebi, J. Kornhuber, J.C. Morris, A.M. Fagan, Cerebrospinal Fluid A\u03b242\/40 Corresponds Better than A\u03b242 to Amyloid PET in Alzheimer\u2019s Disease, J. Alzheimers Dis. 55 (n.d.) 813\u2013822. doi: 10.3233\/JAD-160722.","DOI":"10.3233\/JAD-160722"},{"key":"10.1016\/j.cca.2024.119857_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnagi.2014.00047","article-title":"Meta-Review of CSF Core Biomarkers in Alzheimer\u2019s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria","volume":"6","author":"Ferreira","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3233\/JAD-2011-110458","article-title":"Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer\u2019s Disease","volume":"26","author":"Bloudek","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2024.119857_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00430-x","article-title":"Moving fluid biomarkers for Alzheimer\u2019s disease from research tools to routine clinical diagnostics","volume":"16","author":"Zetterberg","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cca.2024.119857_b0115","doi-asserted-by":"crossref","first-page":"e12154","DOI":"10.1002\/trc2.12154","article-title":"Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer\u2019s disease","volume":"7","author":"Tissot","year":"2021","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.cca.2024.119857_b0120","doi-asserted-by":"crossref","unstructured":"N.J. Ashton, A.L. Benedet, T.A. Pascoal, T.K. Karikari, J. Lantero-Rodriguez, W.S. Brum, S. Mathotaarachchi, J. Therriault, M. Savard, M. Chamoun, E. Stoops, C. Francois, E. Vanmechelen, S. Gauthier, E.R. Zimmer, H. Zetterberg, K. Blennow, P. Rosa-Neto, Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer\u2019s disease, eBioMedicine 76 (2022). doi: 10.1016\/j.ebiom.2022.103836.","DOI":"10.1016\/j.ebiom.2022.103836"},{"key":"10.1016\/j.cca.2024.119857_b0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2008.11.023","article-title":"Levels of soluble and insoluble tau reflect overall status of tau phosphorylation in vivo","volume":"450","author":"Hirata-Fukae","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2024.119857_b0130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0135","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/s41467-022-30585-0","article-title":"Fluent molecular mixing of Tau isoforms in Alzheimer\u2019s disease neurofibrillary tangles","volume":"13","author":"Dregni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2024.119857_b0140","doi-asserted-by":"crossref","first-page":"37967","DOI":"10.1074\/jbc.M105365200","article-title":"Interaction of Tau Isoforms with Alzheimer\u2019s Disease Abnormally Hyperphosphorylated Tau and in VitroPhosphorylation into the Disease-like Protein*","volume":"276","author":"Alonso","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2024.119857_b0145","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41380-023-01950-2","article-title":"In vitro evidence for a nonselective 4R tau PET tracer","volume":"28","author":"Betthauser","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cca.2024.119857_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cca.2024.119857_b0155","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/biomedicines10040850","article-title":"Development of Alzheimer\u2019s Disease Biomarkers: From CSF- to Blood-Based Biomarkers","volume":"10","author":"Mankhong","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2024.119857_b0160","doi-asserted-by":"crossref","first-page":"e12270","DOI":"10.1002\/trc2.12270","article-title":"A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer\u2019s disease","volume":"8","author":"Brum","year":"2022","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.cca.2024.119857_b0165","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2024.119857_b0170","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0175","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/bios13070742","article-title":"Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer\u2019s Disease","volume":"13","author":"Sharma","year":"2023","journal-title":"Biosensors"},{"key":"10.1016\/j.cca.2024.119857_b0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13024-022-00586-0","article-title":"Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer\u2019s disease continuum","volume":"17","author":"Gobom","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cca.2024.119857_b0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/epr.10.75","article-title":"Recent cerebrospinal fluid biomarker studies of Alzheimer\u2019s disease","volume":"7","author":"Choi","year":"2010","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.cca.2024.119857_b0190","doi-asserted-by":"crossref","first-page":"e1137","DOI":"10.1212\/WNL.0000000000200040","article-title":"Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration","volume":"98","author":"Mattsson-Carlgren","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.119857_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/brainsci10010056","article-title":"Neurofilaments: The C-Reactive Protein of Neurology","volume":"10","author":"Lambertsen","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.cca.2024.119857_b0200","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ene.15058","article-title":"Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia","volume":"29","author":"Silva-Sp\u00ednola","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2024.119857_b0210","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1007\/s12035-020-02035-9","article-title":"Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases","volume":"57","author":"Palermo","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cca.2024.119857_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120088","article-title":"Cerebrospinal fluid neurofilament light predicts the rate of executive function decline in younger-onset dementia","volume":"432","author":"Walia","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0220","first-page":"317","article-title":"Biological Biosensors for Monitoring and Diagnosis","author":"Singh","year":"2020","journal-title":"Microb. Biotechnol. Basic Res. Appl."},{"key":"10.1016\/j.cca.2024.119857_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.151661","article-title":"Navigating the landscape of optical biosensors","author":"Sagar Shrikrishna","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.cca.2024.119857_b0230","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00604-020-04503-4","article-title":"Microfluidic electrochemical immunosensor for the determination of cystatin C in human serum","volume":"187","author":"Devi","year":"2020","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.cca.2024.119857_b0235","article-title":"A neurofilament-light chains electrochemical immunosensor expected to reveal the early stage of neurodegenerative diseases","volume":"446","author":"Li","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.cca.2024.119857_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.matlet.2021.130798","article-title":"Photoelectrochemical sensor for detection of serum neurofilament light chain based on organic semiconductor modified electrode","volume":"305","author":"Chen","year":"2021","journal-title":"Mater. Lett."},{"key":"10.1016\/j.cca.2024.119857_b0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4155\/bio-2019-0221","article-title":"Evaluation of single molecule array digital immunoassay technology to quantitate neurofilament light chain","volume":"12","author":"Midde","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.cca.2024.119857_b0250","doi-asserted-by":"crossref","first-page":"2200044","DOI":"10.1002\/adpr.202200044","article-title":"Ultrahigh Sensitive Detection of Tau Protein as Alzheimer\u2019s Biomarker via Microfluidics and Nanofunctionalized Optical Fiber Sensors","volume":"3","author":"Chiavaioli","year":"2022","journal-title":"Adv. Photonics Res."},{"key":"10.1016\/j.cca.2024.119857_b0255","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.nano.2018.05.013","article-title":"Rapid multiplexed detection of beta-amyloid and total-tau as biomarkers for Alzheimer\u2019s disease in cerebrospinal fluid","volume":"14","author":"Song","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.cca.2024.119857_b0260","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.snb.2018.07.078","article-title":"Curcumin-based electrochemical sensor of amyloid-\u03b2 oligomer for the early detection of Alzheimer\u2019s disease","volume":"273","author":"Qin","year":"2018","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.cca.2024.119857_b0265","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s43587-022-00300-1","article-title":"CSF proteome profiling across the Alzheimer\u2019s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels","volume":"2","author":"del Campo","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.cca.2024.119857_b0270","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000488481","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative, Cerebrospinal Fluid BACE1 Activity and sA\u03b2PP\u03b2 as Biomarker Candidates of Alzheimer\u2019s Disease","volume":"45","author":"Alexopoulos","year":"2018","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.cca.2024.119857_b0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2010-1367","article-title":"BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology","volume":"20","author":"Mulder","year":"2010","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.cca.2024.119857_b0280","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","article-title":"Texas Alzheimer\u2019s Research Consortium, Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer\u2019s research consortium study","volume":"65","author":"O\u2019Bryant","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0285","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00401-022-02469-6","article-title":"Galectin-3 is elevated in CSF and is associated with A\u03b2 deposits and tau aggregates in brain tissue in Alzheimer\u2019s disease","volume":"144","author":"Boza-Serrano","year":"2022","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.cca.2024.119857_b0290","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1038\/s41598-020-63255-6","article-title":"Neuroligin-1 is altered in the hippocampus of Alzheimer\u2019s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers","volume":"10","author":"Dufort-Gervais","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.119857_b0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-021-01119-4","article-title":"Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers","volume":"9","author":"Camporesi","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cca.2024.119857_b0300","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13195-020-00655-w","article-title":"CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer\u2019s disease","volume":"12","author":"Mouton-Liger","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-022-01014-7","article-title":"Plasma neuregulin 1 as a synaptic biomarker in Alzheimer\u2019s disease: a discovery cohort study","volume":"14","author":"Vrillon","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0310","first-page":"1","article-title":"Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer\u2019s disease and mild cognitive impairment, Transl","volume":"10","author":"Liu","year":"2020","journal-title":"Psychiatry"},{"key":"10.1016\/j.cca.2024.119857_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.584743","article-title":"Neurogranin: A Potential Biomarker of Neurological and Mental Diseases","volume":"12","author":"Xiang","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0320","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3390\/diagnostics11122339","article-title":"Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer\u2019s Disease","volume":"11","author":"Agnello","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.cca.2024.119857_b0325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13195-021-00861-0","article-title":"VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome","volume":"13","author":"Lle\u00f3","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0330","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.22448","article-title":"Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease","volume":"70","author":"Tarawneh","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0335","first-page":"e12057","article-title":"Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease in a cohort of adults with Down syndrome, Alzheimers Dement","volume":"12","author":"Henson","year":"2020","journal-title":"Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.cca.2024.119857_b0340","doi-asserted-by":"crossref","first-page":"8335","DOI":"10.3390\/ijms21218335","article-title":"Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"21","author":"Dulewicz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-015-0142-1","article-title":"Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer\u2019s disease in a memory clinic cohort","volume":"7","author":"Kester","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0350","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"A. and F. (ALFA) study Translational Biomarkers in Aging and Dementia (TRIAD) study and BioCogBank Paris Lariboisi\u00e8re cohort, Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104539","article-title":"A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases","volume":"90","author":"Raeber","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2024.119857_b0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","article-title":"Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer\u2019s disease-associated biomarkers alterations among de novo Parkinson\u2019s disease patients: a prospective cohort study","volume":"20","author":"Liu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cca.2024.119857_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134658","article-title":"Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer\u2019s disease","volume":"715","author":"Wang","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2024.119857_b0370","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3233\/JAD-191261","article-title":"Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer\u2019s Disease: A Pilot Study","volume":"76","author":"Thordardottir","year":"2020","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.cca.2024.119857_b0375","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000506282","article-title":"Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype","volume":"49","author":"Woollacott","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.cca.2024.119857_b0380","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1038\/s41380-022-01716-2","article-title":"Astrocyte biomarker signatures of amyloid-\u03b2 and tau pathologies in Alzheimer\u2019s disease","volume":"27","author":"Ferrari-Souza","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cca.2024.119857_b0385","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1038\/s41598-020-72878-8","article-title":"Cerebrospinal fluid sTREM2 in Alzheimer\u2019s disease: comparisons between clinical presentation and AT classification","volume":"10","author":"Knapskog","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.119857_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative, Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Su\u00e1rez-Calvet","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cca.2024.119857_b0395","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-018-0407-6","article-title":"the Alzheimer\u2019s Disease Neuroimaging Initiative, Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer\u2019s disease","volume":"10","author":"Zhang","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-215696","article-title":"Cerebrospinal Fluid Synaptosomal-Associated Protein 25 Levels in Patients with Alzheimer\u2019s Disease: A Meta-Analysis","volume":"89","author":"Liu","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2024.119857_b0405","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41582-022-00713-x","article-title":"SNAP25 \u2014 an early biomarker in AD and CJD","volume":"18","author":"Wood","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0410","doi-asserted-by":"crossref","unstructured":"Y. Liu, J.-H. Song, W. Xu, X.-H. Hou, J.-Q. Li, J.-T. Yu, L. Tan, S. Chi, and Alzheimer\u2019s Disease Neuroimaging Initiative, The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer\u2019s Disease: Exploring Interactions With Sex, Front. Neurosci. 15 (2021). https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.633576 (accessed December 2, 2023).","DOI":"10.3389\/fnins.2021.633576"},{"key":"10.1016\/j.cca.2024.119857_b0415","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11011-022-01114-1","article-title":"Blood-based biomarkers in Alzheimer\u2019s disease: a mini-review","volume":"38","author":"Padala","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.cca.2024.119857_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113294","article-title":"Towards point-of-care diagnosis of Alzheimer\u2019s disease: Multi-analyte based portable chemiresistive platform for simultaneous detection of \u03b2-amyloid (1\u201340) and (1\u201342) in plasma","volume":"186","author":"Supraja","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.cca.2024.119857_b0425","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.snb.2016.07.181","article-title":"Alzheimer\u2019s disease: Development of a sensitive label-free electrochemical immunosensor for detection of amyloid beta peptide","volume":"239","author":"Carneiro","year":"2017","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.cca.2024.119857_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339445","article-title":"Highly sensitive surface-enhanced Raman scattering-based immunosensor incorporating half antibody-fragment for quantitative detection of Alzheimer\u2019s disease biomarker in blood","volume":"1195","author":"Yang","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.cca.2024.119857_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112238","article-title":"An electrochemical immunosensor using gold nanoparticles-PAMAM-nanostructured screen-printed carbon electrodes for tau protein determination in plasma and brain tissues from Alzheimer patients","volume":"163","author":"Razzino","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.cca.2024.119857_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2021.131288","article-title":"Nanoparticle-based multiplex biosensor utilising dual dielectrophoretic forces for clinical diagnosis of Alzheimer\u2019s disease","volume":"355","author":"Kim","year":"2022","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.cca.2024.119857_b0445","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbiosc.2021.03.016","article-title":"Development of liquid crystal biosensor for the detection of amyloid beta-42 levels associated with Alzheimer\u2019s disease","volume":"132","author":"Kemiklioglu","year":"2021","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.cca.2024.119857_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113649","article-title":"An SPRi-based biosensor pilot study: Analysis of multiple circulating extracellular vesicles and hippocampal volume in Alzheimer\u2019s disease","volume":"192","author":"Picciolini","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2024.119857_b0455","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.aca.2019.09.042","article-title":"Competitive electrochemical immunosensor for the detection of unfolded p53 protein in blood as biomarker for Alzheimer\u2019s disease","volume":"1093","author":"Amor-Guti\u00e9rrez","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.cca.2024.119857_b0460","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00726-021-02943-7","article-title":"High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer\u2019s disease","volume":"53","author":"Nuzzo","year":"2021","journal-title":"Amino Acids"},{"key":"10.1016\/j.cca.2024.119857_b0465","doi-asserted-by":"crossref","unstructured":"F. Malerba, I. Arisi, R. Florio, C. Zecca, M.T. Dell\u2019Abate, B. Bruni Ercole, S. Camerini, M. Casella, G. Logroscino, A. Cattaneo, proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer\u2019s Disease by a New Automated Immunoassay, Front. Aging Neurosci. 13 (2021). https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.741414 (accessed December 15, 2023).","DOI":"10.3389\/fnagi.2021.741414"},{"key":"10.1016\/j.cca.2024.119857_b0470","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cells11081367","article-title":"Blood-Based Biomarkers for Alzheimer\u2019s Disease Diagnosis and Progression: An Overview","volume":"11","author":"Varesi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cca.2024.119857_b0475","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1\u201342\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103837","article-title":"Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET","volume":"76","author":"Tissot","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2024.119857_b0485","first-page":"1152","article-title":"Brain-derived tau: a novel blood-based biomarker for Alzheimer\u2019s disease-type neurodegeneration, Brain","volume":"146","author":"Gonzalez-Ortiz","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0490","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00604-022-05199-4","article-title":"Portable electrochemical micro-workstation platform for simultaneous detection of multiple Alzheimer\u2019s disease biomarkers","volume":"189","author":"Liu","year":"2022","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.cca.2024.119857_b0495","doi-asserted-by":"crossref","first-page":"e1008058","DOI":"10.1371\/journal.ppat.1008058","article-title":"The power of saliva: Antimicrobial and beyond","volume":"15","author":"Vila","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cca.2024.119857_b0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0976-9668.82322","article-title":"Science behind human saliva","volume":"2","author":"Tiwari","year":"2011","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"10.1016\/j.cca.2024.119857_b0505","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/metabo12070638","article-title":"The New Era of Salivaomics in Dentistry: Frontiers and Facts in the Early Diagnosis and Prevention of Oral Diseases and Cancer","volume":"12","author":"Papale","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2024.119857_b0510","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/cancers12123730","article-title":"CA125 and Ovarian Cancer: A Comprehensive Review","volume":"12","author":"Charkhchi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cca.2024.119857_b0515","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1186\/2001-1326-3-3","article-title":"A review of research on salivary biomarkers for oral cancer detection","volume":"3","author":"Cheng","year":"2014","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cca.2024.119857_b0520","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/172460080001500410","article-title":"CA 15\u20133: A Prognostic Marker in Breast Cancer","volume":"15","author":"Duffy","year":"2000","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.cca.2024.119857_b0525","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1158\/1078-0432.CCR-07-5037","article-title":"Salivary Proteomics for Oral Cancer Biomarker Discovery, Clin. Cancer Res","volume":"14","author":"Hu","year":"2008","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.cca.2024.119857_b0530","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1535370216681550","article-title":"Saliva diagnostics \u2013 Current views and directions","volume":"242","author":"Kaczor-Urbanowicz","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.cca.2024.119857_b0535","first-page":"371","article-title":"The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer\u2019s Disease and Parkinson\u2019s Disease","volume":"11","author":"Pawlik","year":"2021","journal-title":"Diagn. Basel Switz."},{"key":"10.1016\/j.cca.2024.119857_b0540","doi-asserted-by":"crossref","first-page":"4761054","DOI":"10.1155\/2019\/4761054","article-title":"Biomarkers for Alzheimer\u2019s Disease in Saliva: A Systematic Review","volume":"2019","author":"Gleerup","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cca.2024.119857_b0545","first-page":"730","article-title":"Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance, World","volume":"5","author":"Desai","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/j.cca.2024.119857_b0550","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF03324623","article-title":"Age-related changes in unstimulated salivary function and composition and its relations to medications and oral sensorial complaints","volume":"17","author":"Nagler","year":"2005","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.cca.2024.119857_b0555","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jdent.2004.10.009","article-title":"Health benefits of saliva: a review","volume":"33","author":"Dodds","year":"2005","journal-title":"J. Dent."},{"key":"10.1016\/j.cca.2024.119857_b0560","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijms.12912","article-title":"Salivary Secretory Disorders, Inducing Drugs, and Clinical Management","volume":"12","author":"Miranda-Rius","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/odi.12713","article-title":"Oral epithelial MUC1 and oral health","volume":"24","author":"Kho","year":"2018","journal-title":"Oral Dis."},{"key":"10.1016\/j.cca.2024.119857_b0570","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/mutage\/gem029","article-title":"Buccal micronucleus cytome biomarkers may be associated with Alzheimer\u2019s disease","volume":"22","author":"Thomas","year":"2007","journal-title":"Mutagenesis"},{"key":"10.1016\/j.cca.2024.119857_b0575","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2147\/NDT.S157731","article-title":"Cytological and cytometric analysis of oral mucosa in patients with Alzheimer\u2019s and Parkinson\u2019s disease","volume":"14","author":"Kose Ozlece","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.cca.2024.119857_b0580","doi-asserted-by":"crossref","first-page":"M64","DOI":"10.1093\/gerona\/57.1.M64","article-title":"The tau protein of oral epithelium increases in Alzheimer\u2019s disease","volume":"57","author":"Hattori","year":"2002","journal-title":"J. Gerontol. a. Biol. Sci. Med. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0585","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-130866","article-title":"Three-dimensional quantitative imaging of telomeres in buccal cells identifies mild, moderate, and severe Alzheimer\u2019s disease patients","volume":"39","author":"Mathur","year":"2014","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.cca.2024.119857_b0590","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1567205015666181022094924","article-title":"Current State of Saliva Biomarkers for Aging and Alzheimer\u2019s Disease","volume":"16","author":"Fran\u00e7ois","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cca.2024.119857_b0595","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3390\/jcm9061673","article-title":"Diagnostic Biomarkers for Alzheimer\u2019s Disease Using Non-Invasive Specimens","volume":"9","author":"Paraskevaidi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2024.119857_b0600","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2377-10-108","article-title":"Saliva levels of Abeta1-42 as potential biomarker of Alzheimer\u2019s disease: a pilot study","volume":"10","author":"Bermejo-Pareja","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0605","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-160748","article-title":"A Method for Diagnosing Alzheimer\u2019s Disease Based on Salivary Amyloid-\u03b2 Protein 42 Levels","volume":"55","author":"Lee","year":"2017","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.cca.2024.119857_b0610","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.archoralbio.2019.06.004","article-title":"Salivary biological biomarkers for Alzheimer\u2019s disease","volume":"105","author":"Liang","year":"2019","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.cca.2024.119857_b0615","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/metabo13020233","article-title":"Salivary Metabolomics in the Diagnosis and Monitoring of Neurodegenerative Dementia","volume":"13","author":"Hyv\u00e4rinen","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2024.119857_b0620","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-110731","article-title":"Salivary tau species are potential biomarkers of Alzheimer\u2019s disease","volume":"27","author":"Shi","year":"2011","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.cca.2024.119857_b0625","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1389203719666180514150921","article-title":"Lactoferrin: Major Physiological Functions and Applications","volume":"20","author":"Hao","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0630","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.dadm.2017.04.002","article-title":"Early diagnosis of mild cognitive impairment and Alzheimer\u2019s disease based on salivary lactoferrin","volume":"8","author":"Carro","year":"2017","journal-title":"Alzheimers Dement. Amst. Neth."},{"key":"10.1016\/j.cca.2024.119857_b0635","first-page":"114","article-title":"Saliva: A tool in assessing glucose levels in Diabetes Mellitus","volume":"6","author":"Satish","year":"2014","journal-title":"J. Int. Oral Health JIOH"},{"key":"10.1016\/j.cca.2024.119857_b0640","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0645","doi-asserted-by":"crossref","first-page":"e0117810","DOI":"10.1371\/journal.pone.0117810","article-title":"Non-Invasive Screening for Alzheimer\u2019s Disease by Sensing Salivary Sugar Using Drosophila Cells Expressing Gustatory Receptor (Gr5a) Immobilized on an Extended Gate Ion-Sensitive Field-Effect Transistor (EG-ISFET) Biosensor","volume":"10","author":"Lau","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2024.119857_b0650","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1110\/ps.052048706","article-title":"Structure and topology of the non-amyloid-beta component fragment of human alpha-synuclein bound to micelles: implications for the aggregation process","volume":"15","author":"Bisaglia","year":"2006","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"10.1016\/j.cca.2024.119857_b0655","first-page":"285","article-title":"Salivary levels of disease-related biomarkers in the early stages of Parkinson\u2019s and Alzheimer\u2019s disease: A cross-sectional study, IBRO Neurosci","volume":"14","author":"Sabaei","year":"2023","journal-title":"Rep."},{"key":"10.1016\/j.cca.2024.119857_b0660","first-page":"153","article-title":"Arizona Parkinson\u2019s Disease Consortium, Prevalence of Submandibular Gland Synucleinopathy in Parkinson\u2019s Disease, Dementia with Lewy Bodies and other Lewy Body Disorders","volume":"6","author":"Beach","year":"2016","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.cca.2024.119857_b0665","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1093\/brain\/awr015","article-title":"Salivary \u03b1-synuclein and DJ-1: potential biomarkers for Parkinson\u2019s disease","volume":"134","author":"Devic","year":"2011","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0670","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-023-00339-z","article-title":"Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases","volume":"12","author":"Sharma","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.cca.2024.119857_b0675","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-180261","article-title":"Urine-Based Biomarkers for Alzheimer\u2019s Disease Identified Through Coupling Computational and Experimental Methods","volume":"65","author":"Yao","year":"2018","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.cca.2024.119857_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8821181","article-title":"Development of an Immunoassay for the Detection of Amyloid Beta 1\u201342 and Its Application in Urine Samples","volume":"2020","author":"Wongta","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cca.2024.119857_b0685","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.urine.2023.06.001","article-title":"Urine; a new promising biological fluid to act as a non-invasive biomarker for different human diseases","volume":"5","author":"Balhara","year":"2023","journal-title":"URINE"},{"key":"10.1016\/j.cca.2024.119857_b0690","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/cmi.2017.94","article-title":"Osteopontin and the immune system: another brick in the wall","volume":"15","author":"Caputo","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2024.119857_b0695","doi-asserted-by":"crossref","unstructured":"Y. Qiu, X. Shen, O. Ravid, D. Atrakchi, D. Rand, A.E. Wight, H.-J. Kim, S. Liraz-Zaltsman, I. Cooper, M. Schnaider Beeri, H. Cantor, Definition of the contribution of an Osteopontin-producing CD11c+ microglial subset to Alzheimer\u2019s disease, Proc. Natl. Acad. Sci. USA 120 (2023) e2218915120. doi: 10.1073\/pnas.2218915120.","DOI":"10.1073\/pnas.2218915120"},{"key":"10.1016\/j.cca.2024.119857_b0700","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.ASN.0000040593.93815.9D","article-title":"Osteopontin Is a Critical Inhibitor of Calcium Oxalate Crystal Formation and Retention in Renal Tubules","volume":"14","author":"Wesson","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2024.119857_b0705","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lfs.2014.01.064","article-title":"Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer\u2019s disease","volume":"99","author":"Yang","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2024.119857_b0710","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/14728222.2010.488222","article-title":"Gelsolin as therapeutic target in Alzheimer\u2019s disease","volume":"14","author":"Carro","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cca.2024.119857_b0715","first-page":"313","article-title":"Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value - a multi-centre cohort study","volume":"32","author":"Puig-Gay","year":"2019","journal-title":"Transpl. Int. off. J. Eur. Soc. Organ Transplant."},{"key":"10.1016\/j.cca.2024.119857_b0720","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/alz.12419","article-title":"Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies","volume":"18","author":"Lindbohm","year":"2022","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.cca.2024.119857_b0725","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/jpm10030061","article-title":"Molecular and Imaging Biomarkers in Alzheimer\u2019s Disease: A Focus on Recent Insights","volume":"10","author":"Villa","year":"2020","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.cca.2024.119857_b0730","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/elps.201300036","article-title":"Detection and Quantification of 8-Hydroxy-2\u2032-Deoxyguanosine in Alzheimer\u2019s Transgenic Mouse Urine using Capillary Electrophoresis","volume":"34","author":"Zhang","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/j.cca.2024.119857_b0735","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.3390\/ijms21197152","article-title":"Neuroprotective Effect of Antioxidants in the Brain","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0740","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1038\/s41467-021-24756-8","article-title":"An enzymatic activation of formaldehyde for nucleotide methylation","volume":"12","author":"Bou-Nader","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2024.119857_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101512","article-title":"Formaldehyde toxicity in age-related neurological dementia","volume":"73","author":"Kou","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cca.2024.119857_b0750","article-title":"Correlation Between Urine Formaldehyde and Cognitive Abilities in the Clinical Spectrum of Alzheimer\u2019s Disease","volume":"14","author":"Wang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0755","doi-asserted-by":"crossref","first-page":"1046066","DOI":"10.3389\/fnagi.2022.1046066","article-title":"Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer\u2019s disease","volume":"14","author":"Wang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0760","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3233\/JAD-160357","article-title":"Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer\u2019s Disease","volume":"55","author":"Tong","year":"2017","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.cca.2024.119857_b0765","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000509561","article-title":"Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer\u2019s Disease","volume":"10","author":"Watanabe","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"10.1016\/j.cca.2024.119857_b0770","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.3390\/ijms231710123","article-title":"Tear Biomarkers in Alzheimer\u2019s and Parkinson\u2019s Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)","volume":"23","author":"Kr\u00f3l-Grzyma\u0142a","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0775","doi-asserted-by":"crossref","first-page":"13429","DOI":"10.3390\/ijms241713429","article-title":"Tear Biomarkers and Alzheimer\u2019s Disease","volume":"24","author":"Ka\u0161telan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0780","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/jpm10030114","article-title":"Biomarkers for Alzheimer\u2019s Disease Early Diagnosis","volume":"10","author":"Aus\u00f3","year":"2020","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.cca.2024.119857_b0785","doi-asserted-by":"crossref","first-page":"22675","DOI":"10.1038\/s41598-021-01993-x","article-title":"Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration","volume":"11","author":"Gijs","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.119857_b0790","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/00001756-200410050-00019","article-title":"Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain","volume":"15","author":"Li","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.cca.2024.119857_b0795","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: Biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cca.2024.119857_b0800","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2024.119857_b0805","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.587747","article-title":"Targeting MicroRNA-125b Promotes Neurite Outgrowth but Represses Cell Apoptosis and Inflammation via Blocking PTGS2 and CDK5 in a FOXQ1-Dependent Way in Alzheimer Disease","volume":"14","author":"Zhuang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.111961","article-title":"Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population","volume":"169","author":"Abuelezz","year":"2022","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.cca.2024.119857_b0815","doi-asserted-by":"crossref","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","article-title":"MiR-26b, Upregulated in Alzheimer\u2019s Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons","volume":"33","author":"Absalon","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0820","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.omtn.2020.01.010","article-title":"miRNA-31 Improves Cognition and Abolishes Amyloid-\u03b2 Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer\u2019s Disease","volume":"19","author":"Barros-Viegas","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.cca.2024.119857_b0825","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fneur.2020.00462","article-title":"microRNA-146a Signaling in Alzheimer\u2019s Disease (AD) and Prion Disease (PrD)","volume":"11","author":"Lukiw","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0830","doi-asserted-by":"crossref","first-page":"2031407","DOI":"10.1155\/2021\/2031407","article-title":"MiR-29c-3p May Promote the Progression of Alzheimer\u2019s Disease through BACE1","volume":"2021","author":"Cao","year":"2021","journal-title":"J. Healthc. Eng."},{"key":"10.1016\/j.cca.2024.119857_b0835","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WNR.0000000000001379","article-title":"miR-16-5p and miR-19b-3p prevent amyloid \u03b2-induced injury by targeting BACE1 in SH-SY5Y cells","volume":"31","author":"Zhang","year":"2020","journal-title":"Neuroreport"},{"key":"10.1016\/j.cca.2024.119857_b0840","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1021\/acschemneuro.2c00423","article-title":"MiR-191-5p Attenuates Tau Phosphorylation, A\u03b2 Generation, and Neuronal Cell Death by Regulating Death-Associated Protein Kinase 1","volume":"13","author":"Wang","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0845","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3892\/mmr.2014.2484","article-title":"MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer\u2019s disease","volume":"10","author":"Liu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cca.2024.119857_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116793","article-title":"miR-34a-5p and miR-125b-5p attenuate A\u03b2-induced neurotoxicity through targeting BACE1","volume":"413","author":"Li","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0855","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-020-00627-0","article-title":"and the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing, Differential blood miRNA expression in brain amyloid imaging-defined Alzheimer\u2019s disease and controls","volume":"12","author":"Wu","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b0860","article-title":"Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2024.119857_b0865","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1567202617666200414142637","article-title":"Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and A\u03b2 Accumulation in the Alzheimer\u2019s Disease Mice by Targeting DYRK1A","volume":"17","author":"Liu","year":"2020","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.cca.2024.119857_b0870","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.3892\/mmr.2015.4339","article-title":"Downregulated microRNA-222 is correlated with increased p27Kip1 expression in a double transgenic mouse model of Alzheimer\u2019s disease","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cca.2024.119857_b0875","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00091","article-title":"miR-103 Promotes Neurite Outgrowth and Suppresses Cells Apoptosis by Targeting Prostaglandin-Endoperoxide Synthase 2 in Cellular Models of Alzheimer\u2019s Disease","volume":"12","author":"Yang","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41525-022-00319-8","article-title":"Synaptosome microRNAs regulate synapse functions in Alzheimer\u2019s disease","volume":"7","author":"Kumar","year":"2022","journal-title":"Npj Genomic Med."},{"key":"10.1016\/j.cca.2024.119857_b0885","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.23588","article-title":"miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model","volume":"72","author":"Lee","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2024.119857_b0890","article-title":"Alzheimer\u2019s Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0895","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/ijms19082323","article-title":"miRNA-34c Overexpression Causes Dendritic Loss and Memory Decline","volume":"19","author":"Kao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119857_b0900","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.sna.2018.06.026","article-title":"Impedimetric detection of miRNA-34a using graphene oxide modified chemically activated graphite electrodes","volume":"279","author":"Congur","year":"2018","journal-title":"Sens. Actuators Phys."},{"key":"10.1016\/j.cca.2024.119857_b0905","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/23328940.2019.1632145","article-title":"Physiology of sweat gland function: The roles of sweating and sweat composition in human health","volume":"6","author":"Baker","year":"2019","journal-title":"Temperature"},{"key":"10.1016\/j.cca.2024.119857_b0910","doi-asserted-by":"crossref","first-page":"39039","DOI":"10.1021\/acsomega.2c04789","article-title":"Molecular Imprinted Polymers on Microneedle Arrays for Point of Care Transdermal Sampling and Sensing of Inflammatory Biomarkers","volume":"7","author":"Oliveira","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.cca.2024.119857_b0915","first-page":"50","article-title":"Increased sweat sodium concentration in patients with Alzheimer\u2019s disease","volume":"4","author":"Elmst\u00e5hl","year":"1993","journal-title":"Dement. Basel Switz."},{"key":"10.1016\/j.cca.2024.119857_b0920","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-3223(94)00116-K","article-title":"Muscarinic receptors on human eccrine sweat gland in aging and Alzheimer\u2019s disease","volume":"37","author":"Ryer","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cca.2024.119857_b0925","first-page":"e688","article-title":"Validation of Plasma Amyloid-\u03b2 42\/40 for Detecting Alzheimer Disease Amyloid Plaques","volume":"98","author":"Li","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.119857_b0930","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1212\/WNL.0000000000201401","article-title":"Menopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women","volume":"100","author":"Thurston","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.119857_b0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41378-022-00443-6","article-title":"Wearable and flexible electrochemical sensors for sweat analysis: a review","volume":"9","author":"Gao","year":"2023","journal-title":"Microsyst. Nanoeng."},{"key":"10.1016\/j.cca.2024.119857_b0940","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41391-021-00472-8","article-title":"Overview of seminal fluid biomarkers for the evaluation of chronic prostatitis: a scoping review","volume":"25","author":"Moryousef","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.cca.2024.119857_b0945","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1471-4159.2009.06566.x","article-title":"Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease","volume":"112","author":"Rosi","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2024.119857_b0950","first-page":"ioad127","article-title":"Presence of key cholinergic enzymes in human spermatozoa and seminal fluid\u2020","author":"Thakur","year":"2023","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cca.2024.119857_b0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.103625","article-title":"Nipple aspirate fluid and its use for the early detection of breast cancer","volume":"77","author":"Jiwa","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.cca.2024.119857_b0960","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jinorgbio.2013.07.003","article-title":"Aluminium, carbonyls and cytokines in human nipple aspirate fluids: Possible relationship between inflammation, oxidative stress and breast cancer microenvironment","volume":"128","author":"Mannello","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cca.2024.119857_b0965","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0009-9120(00)00185-5","article-title":"Human kallikrein 6 as a biomarker of alzheimer\u2019s disease","volume":"33","author":"Diamandis","year":"2000","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2024.119857_b0970","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18632\/aging.100004","article-title":"Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging","volume":"1","author":"Perdomo","year":"2008","journal-title":"Aging"},{"key":"10.1016\/j.cca.2024.119857_b0975","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12031-018-1217-9","article-title":"Apolipoprotein D Upregulation in Alzheimer\u2019s Disease but Not Frontotemporal Dementia","volume":"67","author":"Bhatia","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cca.2024.119857_b0980","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00702-022-02461-0","article-title":"Don\u2019t forget about tau: the effects of ApoE4 genotype on Alzheimer\u2019s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment\u2014data from the Dementia Competence Network","volume":"129","author":"Benson","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cca.2024.119857_b0985","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","article-title":"Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease","volume":"67","author":"Thambisetty","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cca.2024.119857_b0990","doi-asserted-by":"crossref","first-page":"e0166369","DOI":"10.1371\/journal.pone.0166369","article-title":"Role of Plasma Clusterin in Alzheimer\u2019s Disease\u2014A Pilot Study in a Tertiary Hospital in Northern India","volume":"11","author":"Vishnu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2024.119857_b0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.cca.2024.119857_b1000","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jnnp-2022-329663","article-title":"Plasma GFAP in presymptomatic and symptomatic familial Alzheimer\u2019s disease: a longitudinal cohort study","volume":"94","author":"O\u2019Connor","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2024.119857_b1005","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/alz.12809","article-title":"Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"19","author":"Nilsson","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2024.119857_b1010","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.119857_b1015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-019-0564-2","article-title":"CSF synaptic protein concentrations are raised in those with atypical Alzheimer\u2019s disease but not frontotemporal dementia","volume":"11","author":"Clarke","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2024.119857_b1020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","article-title":"YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias","volume":"12","author":"Llorens","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cca.2024.119857_b1025","doi-asserted-by":"crossref","first-page":"17392","DOI":"10.1038\/s41598-022-20324-2","article-title":"CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer\u2019s disease","volume":"12","author":"Qiang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.119857_b1030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2024.119857_b1035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s12276-020-0418-9","article-title":"New fluid biomarkers tracking non-amyloid-\u03b2 and non-tau pathology in Alzheimer\u2019s disease","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124021090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124021090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T14:14:52Z","timestamp":1728396892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124021090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":207,"alternative-id":["S0009898124021090"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119857","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119857"}}